Related references
Note: Only part of the references are listed.AMPK and mTOR in Cellular Energy Homeostasis and Drug Targets
Ken Inoki et al.
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 52 (2012)
Metformin and cancer therapy
Frederic Bost et al.
CURRENT OPINION IN ONCOLOGY (2012)
Eukaryotic initiation factor 4F: a vulnerability of tumor cells
Teresa Lee et al.
FUTURE MEDICINAL CHEMISTRY (2012)
Role of AMPK-mTOR-Ulk1/2 in the Regulation of Autophagy: Cross Talk, Shortcuts, and Feedbacks
Sebastian Alers et al.
MOLECULAR AND CELLULAR BIOLOGY (2012)
ETV6-RUNX1-positive childhood acute lymphoblastic leukemia: improved outcome with contemporary therapy
D. Bhojwani et al.
LEUKEMIA (2012)
AMP-dependent kinase/mammalian target of rapamycin complex 1 signaling in T-cell acute lymphoblastic leukemia: therapeutic implications
C. Grimaldi et al.
LEUKEMIA (2012)
TDP-43 regulates global translational yield by splicing of exon junction complex component SKAR
Fabienne C. Fiesel et al.
NUCLEIC ACIDS RESEARCH (2012)
Metformin and neoplasia: Implications and indications
Ahmad Aljada et al.
PHARMACOLOGY & THERAPEUTICS (2012)
Antileukemic effects of AMPK activators on BCR-ABL-expressing cells
Eliza Vakana et al.
BLOOD (2011)
Evidence for biological effects of metformin in operable breast cancer: a pre-operative, window-of-opportunity, randomized trial
Sirwan Hadad et al.
BREAST CANCER RESEARCH AND TREATMENT (2011)
Class IIa Histone Deacetylases Are Hormone-Activated Regulators of FOXO and Mammalian Glucose Homeostasis
Maria M. Mihaylova et al.
CELL (2011)
Signal transduction inhibitors in chronic lymphocytic leukemia
Shuo Ma et al.
CURRENT OPINION IN ONCOLOGY (2011)
Minireview: IGF, Insulin, and Cancer
Emily J. Gallagher et al.
ENDOCRINOLOGY (2011)
AMP-activated protein kinase-an energy sensor that regulates all aspects of cell function
D. Grahame Hardie
GENES & DEVELOPMENT (2011)
Regulation of Ribosomal Protein S6 Phosphorylation by Casein Kinase 1 and Protein Phosphatase 1
John A. Hutchinson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Cell cycle regulation in hematopoietic stem cells
Eric M. Pietras et al.
JOURNAL OF CELL BIOLOGY (2011)
Metformin Induces Rab4 Through AMPK and Modulates GLUT4 Translocation in Skeletal Muscle Cells
Jung Ok Lee et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2011)
Biology, Risk Stratification, and Therapy of Pediatric Acute Leukemias: An Update
Ching-Hon Pui et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Cell-Type-Dependent Regulation of mTORC1 by REDD1 and the Tumor Suppressors TSC1/TSC2 and LKB1 in Response to Hypoxia
Nicholas C. Wolff et al.
MOLECULAR AND CELLULAR BIOLOGY (2011)
AMPK and Akt Determine Apoptotic Cell Death following Perturbations of One-Carbon Metabolism by Regulating ER Stress in Acute Lymphoblastic Leukemia
Jeffim N. Kuznetsov et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Targeted inhibition of mTORC1 and mTORC2 by active-site mTOR inhibitors has cytotoxic effects in T-cell acute lymphoblastic leukemia
C. Evangelisti et al.
LEUKEMIA (2011)
Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway
A. M. Martelli et al.
LEUKEMIA (2011)
Structure of mammalian AMPK and its regulation by ADP
Bing Xiao et al.
NATURE (2011)
Inactivation of Rheb by PRAK-mediated phosphorylation is essential for energy-depletion-induced suppression of mTORC1
Min Zheng et al.
NATURE CELL BIOLOGY (2011)
AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1
Joungmok Kim et al.
NATURE CELL BIOLOGY (2011)
The biological and therapeutic relevance of mRNA translation in cancer
Sarah P. Blagden et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2011)
mTOR: from growth signal integration to cancer, diabetes and ageing
Roberto Zoncu et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2011)
The long and winding road to rational treatment of cancer associated with LKB1/AMPK/TSC/mTORC1 signaling
W. van Veelen et al.
ONCOGENE (2011)
Optimizing the selection of kinase inhibitors for chronic myeloid leukemia patients
Devendra K. Hiwase et al.
EXPERT REVIEW OF HEMATOLOGY (2011)
Metformin: Multi-faceted protection against cancer
Sonia Del Barco et al.
ONCOTARGET (2011)
Pharmacological Management of Type 2 Diabetes Mellitus: An Update
Samer El-Kaissi et al.
CURRENT DIABETES REVIEWS (2011)
Autophagy augmented by troglitazone is independent of EGFR transactivation and correlated with AMP-activated protein kinase signaling
Jinguo Yan et al.
AUTOPHAGY (2010)
AMPK- and p62/SQSTM1-dependent autophagy mediate resveratrol-induced cell death in chronic myelogenous leukemia
Alexandre Puissant et al.
AUTOPHAGY (2010)
The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis
Alberto M. Martelli et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2010)
Dissecting the role of mTOR: Lessons from mTOR inhibitors
Ryan J. O. Dowling et al.
BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS (2010)
The LKB1/AMPK signaling pathway has tumor suppressor activity in acute myeloid leukemia through the repression of mTOR-dependent oncogenic mRNA translation
Alexa S. Green et al.
BLOOD (2010)
AICAR induces apoptosis independently of AMPK and p53 through up-regulation of the BH3-only proteins BIM and NOXA in chronic lymphocytic leukemia cells
Antonio F. Santidrian et al.
BLOOD (2010)
Drugging the PI3 Kinome: From Chemical Tools to Drugs in the Clinic
Paul Workman et al.
CANCER RESEARCH (2010)
Resveratrol Promotes Autophagic Cell Death in Chronic Myelogenous Leukemia Cells via JNK-Mediated p62/SQSTM1 Expression and AMPK Activation
Alexandre Puissant et al.
CANCER RESEARCH (2010)
Use of Cells Expressing γ Subunit Variants to Identify Diverse Mechanisms of AMPK Activation
Simon A. Hawley et al.
CELL METABOLISM (2010)
Interdependence of AMPK and SIRT1 for Metabolic Adaptation to Fasting and Exercise in Skeletal Muscle
Carles Canto et al.
CELL METABOLISM (2010)
Metformin, Independent of AMPK, Inhibits mTORC1 in a Rag GTPase-Dependent Manner
Adem Kalender et al.
CELL METABOLISM (2010)
Dual Inhibition of PI3K and mTORC1/2 Signaling by NVP-BEZ235 as a New Therapeutic Strategy for Acute Myeloid Leukemia
Nicolas Chapuis et al.
CLINICAL CANCER RESEARCH (2010)
The role of the Atg1/ULK1 complex in autophagy regulation
Noboru Mizushima
CURRENT OPINION IN CELL BIOLOGY (2010)
Metformin in Cancer Therapy: A New Perspective for an Old Antidiabetic Drug?
Issam Ben Sahra et al.
MOLECULAR CANCER THERAPEUTICS (2010)
Regulation of the mTOR Complex 1 Pathway by Nutrients, Growth Factors, and Stress
Shomit Sengupta et al.
MOLECULAR CELL (2010)
Lkb1 regulates cell cycle and energy metabolism in haematopoietic stem cells
Daisuke Nakada et al.
NATURE (2010)
The Lkb1 metabolic sensor maintains haematopoietic stem cell survival
Sushma Gurumurthy et al.
NATURE (2010)
Lkb1 regulates quiescence and metabolic homeostasis of haematopoietic stem cells
Boyi Gan et al.
NATURE (2010)
Genome-wide RNA-mediated interference screen identifies miR-19 targets in Notch-induced T-cell acute lymphoblastic leukaemia
Konstantinos J. Mavrakis et al.
NATURE CELL BIOLOGY (2010)
Different Effects of Thiazolidinediones on Cardiovascular Risk in Patients with Type 2 Diabetes Mellitus: Pioglitazone vs Rosiglitazone
Rafael Simo et al.
CURRENT DRUG SAFETY (2010)
Histological evaluation of AMPK signalling in primary breast cancer
Sirwan M. Hadad et al.
BMC CANCER (2009)
Targeting translation in acute myeloid leukemia A new paradigm for therapy?
Jerome Tamburini et al.
CELL CYCLE (2009)
Targeted Elimination of Leukemia Stem Cells; a New Therapeutic Approach in Hemato-Oncology
B. Cate et al.
CURRENT DRUG TARGETS (2009)
Inhibition of Contraction-Stimulated AMP-Activated Protein Kinase Inhibits Contraction-Stimulated Increases in PAS-TBC1D1 and Glucose Transport Without Altering PAS-AS160 in Rat Skeletal Muscle
Katsuhiko Funai et al.
DIABETES (2009)
New Users of Metformin Are at Low Risk of Incident Cancer A cohort study among people with type 2 diabetes
Gillian Libby et al.
DIABETES CARE (2009)
The 5′ adenosine monophosphate-activated protein kinase: Regulating the ebb and flow of cellular energetics
Leonidas G. Karagounis et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2009)
Mechanism of PDK1-catalyzed Thr-229 Phosphorylation of the S6K1 Protein Kinase
Malik M. Keshwani et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
Cardiac-specific Deletion of LKB1 Leads to Hypertrophy and Dysfunction
Yasumasa Ikeda et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2009)
LKB1 and Mammalian Target of Rapamycin As Predictive Factors for the Anticancer Efficacy of Metformin
Regan M. Memmott et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Interferon-Dependent Engagement of Eukaryotic Initiation Factor 4B via S6 Kinase (S6K)-and Ribosomal Protein S6K-Mediated Signals
Barbara Kroczynska et al.
MOLECULAR AND CELLULAR BIOLOGY (2009)
AMP-activated protein kinase promotes human prostate cancer cell growth and survival
Hyeon Ung Park et al.
MOLECULAR CANCER THERAPEUTICS (2009)
Targeting the leukemic stem cell: the Holy Grail of leukemia therapy
N. Misaghian et al.
LEUKEMIA (2009)
Stabilization and activation of p53 downregulates mTOR signaling through AMPK in mantle cell lymphoma
E. Drakos et al.
LEUKEMIA (2009)
Somatic LKB1 Mutations Promote Cervical Cancer Progression
Shana N. Wingo et al.
PLOS ONE (2009)
Acadesine Kills Chronic Myelogenous Leukemia (CML) Cells through PKC-Dependent Induction of Autophagic Cell Death
Guillaume Robert et al.
PLOS ONE (2009)
The LKB1-AMPK pathway: metabolism and growth control in tumour suppression
David B. Shackelford et al.
NATURE REVIEWS CANCER (2009)
Antidiabetic Medication and Prostate Cancer Risk: A population-based Case-Control Study
Teemu J. Murtola et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2008)
Malonyl-CoA, a key signaling molecule in mammalian cells
David Saggerson
ANNUAL REVIEW OF NUTRITION (2008)
The role of TOR in autophagy regulation from yeast to plants and mammals
Sandra Diaz-Troya et al.
AUTOPHAGY (2008)
Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators
Shuai Chen et al.
BIOCHEMICAL JOURNAL (2008)
Important role of the LKB1-AMPK pathway in suppressing tumorigenesis in PTEN-deficient mice
Xu Huang et al.
BIOCHEMICAL JOURNAL (2008)
Translation inhibitor Pdcd4 is targeted for degradation during tumor promotion
Tobias Schmid et al.
CANCER RESEARCH (2008)
Transcriptional control of mitochondrial biogenesis:: the central role of PGC-1α
Renee Ventura-Clapier et al.
CARDIOVASCULAR RESEARCH (2008)
p53 target genes Sestrin1 and Sestrin2 connect genotoxic stress and mTOR signaling
Andrei V. Budanov et al.
CELL (2008)
AMP-activated protein kinase regulates GLUT4 transcription by phosphorylating histone deacetylase 5
Sean L. McGee et al.
DIABETES (2008)
Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: A mechanism for the action of berberine to activate AMP-Activated protein kinase and improve insulin action
Nigel Turner et al.
DIABETES (2008)
PTEN posttranslational inactivation and hyperactivation of the PI3K/Akt pathway sustain primary T cell leukemia viability
Ana Silva et al.
JOURNAL OF CLINICAL INVESTIGATION (2008)
AMPK phosphorylation of raptor mediates a metabolic checkpoint
Dana M. Gwinn et al.
MOLECULAR CELL (2008)
Regulation of TORC1 by Rag GTPases in nutrient response
Eunjung Kim et al.
NATURE CELL BIOLOGY (2008)
The antidiabetic drug metformin exerts an antitumoral effect in vitro and in vivo through a decrease of cyclin D1 level
I. Ben Sahra et al.
ONCOGENE (2008)
The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1
Yasemin Sancak et al.
SCIENCE (2008)
Mammalian target of rapamycin (mTOR) inhibition activates phosphatidylinositol 3-kinase/Akt by up-regulating insulin-like growth factor-1 receptor signaling in acute myeloid leukemia: rationale for therapeutic inhibition of both pathways
Jerome Tamburini et al.
BLOOD (2008)
Metformin inhibits mammalian target of rapamycin-dependent translation initiation in breast cancer cells
Ryan J. O. Dowling et al.
CANCER RESEARCH (2007)
Regulation of multisite phosphorylation and 14-3-3 binding of AS160 in response to IGF-1, EGF, PMA and AICAR
Kathryn M. Geraghty et al.
BIOCHEMICAL JOURNAL (2007)
mTOR is the rapamycin-sensitive kinase that confers mechanically-induced phosphorylation of the hydrophobic motif site Thr(389) in p70S6k
Troy Alan Hornberger et al.
FEBS LETTERS (2007)
Activation of adenosine monophosphate activated protein kinase inhibits growth of multiple myeloma cells
Philipp Baumann et al.
EXPERIMENTAL CELL RESEARCH (2007)
AMP-activated/SNF1 protein kinases: conserved guardians of cellular energy
D. Grahame Hardie
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2007)
Mechanism of inhibition of bovine F1-ATPase by resveratrol and related polyphenols
Jonathan R. Gledhill et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Sibylle Jaeger et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Cytotoxic effect of 5-aminoimidazole-4-carboxamide-1-β-4-ribofuranoside (AICAR) on childhood acute lymphoblastic leukemia (ALL) cells:: implication for targeted therapy
Tapas K. Sengupta et al.
MOLECULAR CANCER (2007)
Structure of a CBS-domain pair from the regulatory γ1 subunit of human AMPK in complex with AMP and ZMP
Philip Day et al.
ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY (2007)
Dysfunctional AMPK activity, signalling through mTOR and survival in response to energetic stress in LKB1-deficient lung cancer
J. Carretero et al.
ONCOGENE (2007)
The Bcl-2 apoptotic switch in cancer development and therapy
J. M. Adams et al.
ONCOGENE (2007)
Mammalian TAK1 activates Snf1 protein kinase in yeast and phosphorylates AMP-activated protein kinase in vitro
Milica Momcilovic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Methotrexate enhances the antianabolic and antiproliferative effects of 5-aminoimidazole-4-carboxamide riboside
Annelies Beckers et al.
MOLECULAR CANCER THERAPEUTICS (2006)
Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin - Response to Farooki and Schneider
Samantha L. Bowker et al.
DIABETES CARE (2006)
Increased prevalence of prior breast cancer in women with newly diagnosed diabetes
Lorraine L. Lipscombe et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Diabetes mellitus and breast cancer: a retrospective population-based cohort study
Lorraine L. Lipscombe et al.
BREAST CANCER RESEARCH AND TREATMENT (2006)
Regulation of the energy sensor AMP-activated protein kinase by antigen receptor and Ca2+ in T lymphocytes
Peter Tamas et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Identification and characterization of a small molecule AMPK activator that treats key components of type 2 diabetes and the metabolic syndrome
Barbara Cool et al.
CELL METABOLISM (2006)
Acetyl-CoA carboxylase α is essential to breast cancer cell survival
Veronique Chajes et al.
CANCER RESEARCH (2006)
Insulin antagonizes ischemia-induced Thr172 phosphorylation of AMP-activated protein kinase α-subunits in heart via hierarchical phosphorylation of Ser485/491
S Horman et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2006)
Rosiglitazone suppresses human lung carcinoma cell growth through PPAR-γ-dependent and PPARγ-independent signal pathways
SW Han et al.
MOLECULAR CANCER THERAPEUTICS (2006)
The CREB coactivator TORC2 is a key regulator of fasting glucose metabolism
SH Koo et al.
NATURE (2005)
RNA interference-mediated silencing of the Acetyl-CoA-Carboxylase-α gene induces growth inhibition and apoptosis of prostate cancer cells
K Brusselmans et al.
CANCER RESEARCH (2005)
Calmodulin-dependent protein kinase kinase-β is an alternative upstream kinase for AMP-activated protein kinase
SA Hawley et al.
CELL METABOLISM (2005)
Metformin and reduced risk of cancer in diabetic patients
JMM Evans et al.
BMJ-BRITISH MEDICAL JOURNAL (2005)
Acadesine induces apoptosis in B cells from mantle cell lymphoma and splenic marginal zone lymphoma
C Campàs et al.
LEUKEMIA (2005)
Overweight, obesity and cancer: Epidemiological evidence and proposed mechanisms
EE Calle et al.
NATURE REVIEWS CANCER (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Regulation of the TSC pathway by LKB1: evidence of a molecular link between tuberous sclerosis complex and Peutz-Jeghers syndrome
MN Corradetti et al.
GENES & DEVELOPMENT (2004)
Insulin therapy and colorectal cancer risk among type 2 diabetes mellitus patients
YX Yang et al.
GASTROENTEROLOGY (2004)
TSC2 mediates cellular energy response to control cell growth and survival
K Inoki et al.
CELL (2003)
LKB1 is the upstream kinase in the AMP-activated protein kinase cascade
A Woods et al.
CURRENT BIOLOGY (2003)
MO25α/β interact with STRADα/β enhancing their ability to bind, activate and localize LKB1 in the cytoplasm
J Boudeau et al.
EMBO JOURNAL (2003)
Activation of yeast Snf1 and mammalian AMP-activated protein kinase by upstream kinases
SP Hong et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
Activation of the tumour suppressor kinase LKB1 by the STE20-like pseudokinase STRAD
AF Baas et al.
EMBO JOURNAL (2003)
Acadesine activates AMPK and induces apoptosis in B-cell chronic lymphocytic leukemia cells but not in T lymphocytes
C Campàs et al.
BLOOD (2003)
Regulation of mammalian acetyl-CoA carboxylase
MR Munday
BIOCHEMICAL SOCIETY TRANSACTIONS (2002)
Activation of AMP-activated protein kinase leads to the phosphorylation of elongation factor 2 and an inhibition of protein synthesis
S Horman et al.
CURRENT BIOLOGY (2002)
Functional interleukin-7 receptors (IL-7Rs) are expressed by marrow stromal cells: binding of IL-7 increases levels of IL-6 mRNA and secreted protein
M Iwata et al.
BLOOD (2002)
The anti-diabetic drugs rosiglitazone and metformin stimulate AMP-activated protein kinase through distinct signaling pathways
LGD Fryer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
Identification of the tuberous sclerosis complex-2 tumor suppressor gene product tuberin as a target of the phosphoinositide 3-Kinase/Akt pathway
BD Manning et al.
MOLECULAR CELL (2002)
Regulation of elongation factor 2 kinase by p90RSK1 and p70 S6 kinase
XM Wang et al.
EMBO JOURNAL (2001)
New oral therapies for type 2 diabetes mellitus: The glitazones or insulin sensitizers
S Mudaliar et al.
ANNUAL REVIEW OF MEDICINE (2001)
Phosphorylation and activation of heart PFK-2 by AMPK has a role in the stimulation of glycolysis during ischaemia
AS Marsin et al.
CURRENT BIOLOGY (2000)
Share Paper
